GB201301307D0 - Crystalline form of prulifloxacin and processes for its preparation - Google Patents
Crystalline form of prulifloxacin and processes for its preparationInfo
- Publication number
- GB201301307D0 GB201301307D0 GBGB1301307.3A GB201301307A GB201301307D0 GB 201301307 D0 GB201301307 D0 GB 201301307D0 GB 201301307 A GB201301307 A GB 201301307A GB 201301307 D0 GB201301307 D0 GB 201301307D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- prulifloxacin
- processes
- preparation
- crystalline form
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1920MU2010 | 2010-06-30 | ||
PCT/GB2011/000982 WO2012001357A1 (en) | 2010-06-30 | 2011-06-30 | Crystalline form of prulifloxacin and processes for its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201301307D0 true GB201301307D0 (en) | 2013-03-06 |
GB2498107A GB2498107A (en) | 2013-07-03 |
Family
ID=44454717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1301307.3A Withdrawn GB2498107A (en) | 2010-06-30 | 2011-06-30 | Crystalline form of prulifloxacin and processes for its preparation |
Country Status (3)
Country | Link |
---|---|
GB (1) | GB2498107A (en) |
IN (1) | IN2012MN02925A (en) |
WO (1) | WO2012001357A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102718781B (en) * | 2012-05-08 | 2015-04-29 | 四川科伦药物研究有限公司 | Preparation method of prulifloxacin |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0751579B2 (en) | 1987-11-07 | 1995-06-05 | 日本新薬株式会社 | Quinolinecarboxylic acid derivative |
MXPA05011525A (en) | 2003-04-30 | 2005-12-12 | Nippon Shinyaku Co Ltd | Crystals of quinolinecarboxylic acid derivative solvate. |
EP2081940A4 (en) | 2006-11-17 | 2009-12-02 | Hetero Drugs Ltd | Process for preparation of prulifloxacin using novel intermediates |
US20110034690A1 (en) | 2007-03-14 | 2011-02-10 | Ranbaxy Laboratories Limited | Process for the preparation of pure prulifloxacin |
WO2008111018A2 (en) * | 2007-03-14 | 2008-09-18 | Ranbaxy Laboratories Limited | Process for the preparation of crystals of prulifloxacin |
WO2010084508A2 (en) | 2009-01-14 | 2010-07-29 | Elder Pharmaceuticals Ltd. | Process for the preparation of type i, type ii and type iii crystalline prulifloxacin |
-
2011
- 2011-06-30 WO PCT/GB2011/000982 patent/WO2012001357A1/en active Application Filing
- 2011-06-30 GB GB1301307.3A patent/GB2498107A/en not_active Withdrawn
- 2011-06-30 IN IN2925MUN2012 patent/IN2012MN02925A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2012001357A1 (en) | 2012-01-05 |
GB2498107A (en) | 2013-07-03 |
IN2012MN02925A (en) | 2015-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL237581B (en) | Derivatives of 6-oxo-pyrazinopyrrolopyrimidines | |
PL2609120T3 (en) | Improved process for preparation of sugammadex | |
IL222199A0 (en) | Process for preparation of dopo-derived compounds and compositions thereof | |
HK1178149A1 (en) | Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use -4--- | |
EP2640730A4 (en) | Processes for preparation of everolimus and intermediates thereof | |
PL2785701T3 (en) | Crystalline form of carbazitaxel and process for preparation thereof | |
ZA201204365B (en) | Darunavir polymorph and process for preparation thereof | |
EP2539444A4 (en) | Compositions and methods for the production of l-homoalanine | |
EP2630143A4 (en) | Processes for the preparation of rivaroxaban and intermediates thereof | |
ZA201300776B (en) | Improved process for the preparation of febuxostat | |
PL2528923T3 (en) | Process for the preparation of darunavir and darunavir intermediates | |
EP2563768A4 (en) | Preparation of febuxostat | |
EP2573071A4 (en) | Preparation method of (s)-4-hydroxy-2-oxo-1-pyrrolidine acetamide | |
EP2571355A4 (en) | Crystalline hydrochloride salt of darunavir | |
ZA201207397B (en) | Process for the preparation of dexlansoprazole | |
EP2596007A4 (en) | Process for the preparation of 17-desoxy-corticosteroids | |
ZA201300546B (en) | Process for the preparation of 3-haloalkylpyrazoles | |
PT2655363T (en) | Crystalline forms and processes for their preparation | |
PT2603319E (en) | Process for the preparation of urethans | |
EP2571836A4 (en) | Process for the preparation of hexafluoro-2-butyne | |
PT2390246T (en) | Process for the preparation of aminaphtone | |
EP2578568A4 (en) | Process for preparation of 3-substituted-4-fluoropyrrolidine derivatives | |
GB201301307D0 (en) | Crystalline form of prulifloxacin and processes for its preparation | |
PL2598504T3 (en) | Process for the preparation of dimiracetam | |
EP2459540A4 (en) | Preparation of fipamezole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |